ArticleIranian Red Crescent medical journal2013

Is Certolizumab Pegol Safe and Effective in the Treatment of Patients with Moderate to Severe Crohn's Disease? A Meta-analysis of Controlled Clinical Trials.

Shekoufeh Nikfar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.